Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...

Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...

Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the ...

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

With COVID cases rising in India and several other countries, many people are wondering whether they should get vaccinated.

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA ...

We recently published a list of Jim Cramer Talked About These 13 Stocks. In this article, we are going to take a look at ...

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...